Similar Articles
11 Deciphering the oncogenic role of Rac family small GTPase 3 in hepatocellular carcinoma through multiomics integration
12 Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management
13 Splenectomy and risk of hepatocellular carcinoma
14 Link between type 2 diabetes mellitus and hepatocellular carcinoma
15 Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis
16 Lifestyle factors in hepatocellular carcinoma: From pathogenesis to prognosis
17 Hemostasis: Role of PuraStat® in the prevention and management of gastrointestinal bleeding
18 Pan-cancer analysis of UDP-glucose 6-dehydrogenase in human tumors and its function in hepatocellular carcinoma
19 Integrating radiomics and machine learning for the diagnosis and prognosis of hepatocellular carcinoma
20 Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA